FindTrial
Sign In

The role of plasma protein High Sensitive C-Reactive Protein in judging the amount of disease control in 5 to 12 year old children with asthma

High Sensitive C-Reactive Protein as a marker to assess the degree of symptom control in Asthmatic children aged 5 to 12 years

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032297
Enrollment
335
Registered
2021-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

Dr Niveditha T
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Asthmatic children of the age group 5-12 years attending the Paediatric Medical and Pulmonology OPD and admitted in the Medical and Pulmonology wards

Exclusion criteria

Exclusion criteria: Children with -acute exacerbation of asthma -active respiratory tract infection or any other infection within the past month --systemic inflammatory diseases (such as collagen vascular diseases) -chronic underlying disorders (such as cardiac, pulmonary and renal diseases)

Design outcomes

Primary

MeasureTime frame
To measure the levels of serum High Sensitive C-Reactive Protein in each groupTimepoint: Serum High Sensitive C-Reactive protein values are measured at one single point—

Secondary

MeasureTime frame
To compare the trend of serum hsCRP levels with the level of control of AsthmaTimepoint: The level of control of Asthma symptoms over the past month—

Countries

India

Contacts

Public ContactDr Niveditha T

Institute of Child Health and Hospital for Children

drskalpana@yahoo.co.in9840720234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026